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Abstract 
Drink of the Prophet Mohammad (Kefiran) which is acidifying fermented milk is accepted as a good example of 
a probiotic mixture of bacteria and yeast. In this study colorimetric VITEK-2 Compact system was used to 
identify isolates and to detect susceptibility test to several antimicrobial agents. The study also investigated the 
antimicrobial activity of 24, 48, 72 and 96 hours fermented DPM (kefiran) against isolated bacteria from UTI 
patients. The bacteria isolated were eleven gram negative bacteria, included, Acinetobacter baumannii 8 (8%), 
Enterobacter cloacae 4 (4%), Escherichia coli 16 (15%), Klebsiella oxytoca 6 (6%), Klebsiella pneumonia 11 
(10%),  Micrococcus luteus 3 (3%), Morganella morganii 4 (4%), Proteus mirabilis 7 (7%), Proteus vulgaris 4 
(4%),  Pseudomonas aeruginosa 12 (11%) and Serratia marcescens 4 (4%) and four gram positive bacteria, 
Enterococcus cloacae 2 (2%), Enterococcus faecalis 2 (2%), Staphylococcus aureus 15 (14%), and 
Staphylococcus haemolyticus 6 (6%). The results of antimicrobial susceptibility test against gram negative and 
positive bacteria showed the majority of isolates were resistant to most antimicrobials. The MIC values ranged 
from (≤ 0.125 - ≤ 32 µg/ml). The inhibition zone of 24 hours incubation of DPM (Kefiran) against all isolates 
was between (7-8 mm).The effects at 48hours of incubation of DPM (kefiran) against all isolates was between 
(8-9 mm). The effects at 72 hours of incubation the inhibition zone was between (10-11 mm). The maximum 
activity of the Prophet Mohammad Drink's was recorded at 96 hours of incubation period against all isolates; the 
inhibition zone was between (10-12 mm). 
Keywords: Urinary tract infections, Vitek-2 compact, Drink of the Prophet Mohammad (Kefiran), antimicrobial 
activity, pathogenic bacteria. 
 
1. Introduction 
Drink of the Prophet Mohammad (Kefiran) originated in the Caucasus Mountains several centuries ago and was 
traditionally produced with caprine milk primarily by inhabitants closely associated with the herding of goats 
and sheep. Kefiran (DPM) has a rich history as it pertains to its genesis and spread throughout the regions of the 
Balkan and Caucasus regions of Eastern Europe; in fact, the origins of kefir predate written records. Because of 
its ancient and apparently mysterious origin, kefir was known in antiquity as the “Drink of the Prophet 
Mohammad” and the culture used to prepare it as the “Grains of the Prophet Mohammad”; it was believed that 
the Prophet of Islam, Mohammad, was given the original kefir grains by the Angel Gabriel to be given to his 
followers, thus introducing kefir to the Orthodox Christians living in the mountainous regions of modern day 
Georgia [1, 2, 3].  Historically, kefir grains were considered a gift from Allah among the Muslim people of the 
northern Caucasian mountains. The tribes of the northern Caucasus have produced kefir for hundreds of years. 
They jealously guarded both their kefir grains and the method of fermenting the beverage. These tribes believed 
that the grains were given to them by the Prophet Muhammad, who blessed them with exceptional health-
promoting properties. As a result, the tribes were forbidden to share the grains or the method of preparing kefir 
with outsiders [4]. The word kefir is derived from the Turkish word keyif, which means “feeling good” after its 
ingestion [5, 6]. Grains of the Prophet Mohammad (Milk Kefir Grains) play a natural starter culture role during 
the production of kefir and are recovered after the fermentation process by milk straining [7]. These grains are 
composed of microorganisms immobilized on a polysaccharide and protein matrix, where several species of 
bacteria and yeast coexist in symbiotic association. In this ecosystem there is a relatively stable microorganism 
population, which interacts with and influences other members of the community. This population provides the 
synthesis of bioactive metabolites, which are essential for grain growth and microorganism inhibition, such as 
food pathogens and contaminants [8]. Kefir grains vary in size, from 0.3 to 3.0 cm in diameter are characterized 
by an irregular, multilobular surface, united by a single central section, and their color varies from white to 
yellowish white. The grains are elastic and have a viscous and firm texture [9, 10, and 11]. Kefir possesses 
antimicrobial activity in vitro against a wide variety of Gram- positive and Gram-negative bacteria, as well as 
some fungi [12, 13]. Some coliforms are actively inhited by kefir microorganisms, and pathogenic bacteria such 
as Shigella and Salmonella do not grow when they are introduced to kefir [2, 14].  Lactobacillus acidophilus 
isolated from kefir, shows inhibitory activity against several Gram-positive and Gram-negative microorganisms 
[15, 16, 17, 18]. Of all the kefir starter microbial components, the microphillic homofermentative lactococci and 
acetic acid bacteria are the most active against coliforms. Van Wyk (2001) showed that kefir possesses an 
inhibitory activity against Staphylococcus aureus, Bacillus cereus, Escherichia coli, Clostridium tyrobutyricum 
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and Listeria monocytogenes. Studies have also indicated that yeasts such as Torulaspora, when separated from 
kefir, possess pronounced antimicrobial activity against coliforms [4, 9]. The exact cause of the inhibition is not 
known, but may be due to the antagonistic action of various species of lactic acid bacteria (LAB) [9, 10]. Lactic 
acid bacteria are also capable of preventing the adherence, establishment, replication, and pathogenic action of 
certain enteropathogens [11]. The precise mechanism of this antagonistic activity is not clear, but may include 
the activity of lactic acid or volatile acids, hydroge peroxide [12, 13] Carbon dioxide, acetaldehyde, & diacetyl, 
or bacitracin & bacitracin-like products [2]. Urinary Tract Infections (UTIs) are one of the most prevalent extra-
intestinal bacterial infections. Nowadays, it represents one of the most common diseases encountered in medical 
practice affecting people of all ages from the neonate to the geriatric age group [20]. Worldwide, about 150 
million people are diagnosed with UTI each year [21]. Most infections are caused by retrograde ascent of 
bacteria from the faecal flora via the urethra to the bladder and kidney especially in the females who have a 
shorter and wider urethra and is more readily transfer by microorganisms [22].The structure of the females 
urethra and vagina makes it susceptible to trauma during sexual intercourse as well as bacteria been massaged up 
the urethra and into the bladder during pregnancy and or child birth [23, 24]. Majority of UTIs are not life 
threatening and do not cause any irreversible damage. However, when the kidneys are involved, there is a risk of 
irreparable tissue damage with an increased risk of bacteremia [25]. Many different microorganisms can cause 
UTIs though the most common pathogens causing the simple ones in the community are Escherichia coli and 
other Enterobacteriacae, which accounts approximately 75% of the isolates. In complicated urinary tract 
infections and hospitalized patients, organisms such as Enterococcus faecalis and highly resistant Gram-negative 
rods including Pseudomonas spp. are comparatively more common. The relative frequency of the pathogens 
varies depending upon age, sex, catheterization, and hospitalization [26].  In Iraq the kefir grains are not 
available commercially, and are culturally donated from person to person. The present study was carried out to 
investigate the antimicrobial activity of 24, 48, 72 and 96 hours fermented of kefiran (DPM) against bacteria 
isolated from Urinary tract infections patients. 
 
2. Materials and Methods 
2.1. Isolation & Identification of Bacteria 
This study was carried out in Al-Numan Hospital in Baghdad province, during Jun to 30th September 2013. One 
hundred thirty urine samples were collected from the outpatient with signs and symptoms of UTI. Midstream 
urine samples were collected in sterile containers by using clean and sterile catch method recommended by (Tula, 
and Iyoha, 2014). Then culture on nutrient agar, blood agar and MacConkey agar plates, using sterile standard 
loop (1ml) then incubated at 37ºC for 24-48 hours. The identification of isolates was based on microscopic 
morphology, staining characteristics, culture and biochemical properties using ID card (GN card and GP card), 
Vitek 2 Compact BioMeriux Company [27]. 
2.2. Antimicrobial susceptibility test 
The antimicrobial susceptibility test was performed using several types of AST card, Vitek 2 Compact 
BioMeriux Company [28]. 
2.3. Preparation of Drink of the Prophet Mohammad (Kefiran) 
Starter culture of the prophet Mohammed grains (milk kefir grains) was imported from Kingdom of Jordan. 
DPM was prepared by adding1 liter of milk to 100grams of kefir grains and incubated at room temperature for 
24, 48, 72 and 96 hrs. Subsequently, and filtered through a sterile plastic sieve. The Drink of the Prophet 
Mohammad was then stored in glass container at 8ᵒC in refrigerator until used [6]. 
2.4 Antimicrobial Activity of Drink of the Prophet Mohammed (Kefiran) 
Antimicrobial activity was demonstrated by agar diffusion assay. Mueller Hilton agar medium (20 mL) was 
poured into each Petri dish (90 mm diameter). Suspensions (100 µL) of target strain cultured for 24 hrs. were 
spread on the plates uniformly, and a wells of 6 mm diameter were made with a sterile cork porer. (100 µ L) of 
the Prophet Mohammed Drink (Kefiran) samples were transferred into the wells of agar plates inoculated with 
target strains. The plates were incubated at 37 °C. The diameter of inhibition zone was measured after 12-15 hrs. 
DPM (Kefiran) sample was taking after (0, 24, 48, 72 and 96 hrs.) of incubation [13]. 
 
3. Results 
The bacteria isolated from UTI patient samples are shown in (Table 1). Eleven gram negative bacteria, included, 
Acinetobacter baumannii 8 (8%), Enterobacter cloacae 4 (4%), Escherichia coli 16 (15%), Klebsiella oxytoca 6 
(6%), Klebsiella pneumonia 11 (10%),  Micrococcus luteus 3 (3%), Morganella morganii 4 (4%), Proteus 
mirabilis 7 (7%), Proteus vulgaris 4 (4%), Pseudomonas aeruginosa 12 (11%) and Serratia marcescens 4 (4%) 
and four gram positive bacteria, Enterococcus cloacae 2 (2%), Enterococcus faecalis 2 (2%), Staphylococcus 
aureus 15 (14%), and Staphylococcus haemolyticus 6 (6%). 
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Table 1: Bacteria isolated from Urinary tract infections patients. 
Isolate No. Percentage 
Acinetobacter baumannii 8    8 
Enterobacter cloacae 4 4 
Escherichia coli 16 15 
Klebsiella oxytoca 6 6 
Klebsiella pneumonia 11 10 
Micrococcus luteus 3 3 
Morganella morganii 4 4 
Proteus mirabilis 7 7 
Proteus vulgaris 4 4 
Pseudomonas aeruginosa 12 11 
Serratia marcescens 4 4 
Enterococcus cloacae 2 2 
Enterococcus faecalis 2 2 
Staphylococcus aureus 15 14 
Staphylococcus haemolyticus 6 6 
Total 104 100 
      
The results of antimicrobial susceptibility test against gram negative bacteria shows the all isolates were resistant 
to Ampicillin, Amoxicillin/Clavulanic Acid, Cefazolin, Ceftriaxone, Aztreonam, Gentamicin, Tetracycline and 
Ttimethprim / Sulfamethoxazole, and sensitive to Piperacillin/Tazobactam, Cefepime, Ertapenem, Imipenem, 
Meropenem, Amikacin, Ciprofloxacin and Levofloxacin (Table 2).  
  
Table 2: Susceptibility tests of antimicrobials on gram negative bacteria isolated from UTI patients. 
Bacterial isolates Percentage of resistance 
AM AUC PPL CZ CI CEF AZ EPM 
Acinetobacter baumannii 88 80 39 81 84 44 77 30 
Enterobacter cloacae 90 81 37 83 82 40 75 31 
Escherichia coli 91 85 45 82 81 42 74 33 
Klebsiella oxytoca 87 83 40 88 85 43 76 36 
Klebsiella pneumonia 90 81 41 80 90 44 77 31 
Micrococcus luteus 85 77 38 82 86 46 71 35 
Morganella morganii 87 79 39 83 94 47 73 37 
Proteus mirabilis 84 81 40 84 81 41 77 31 
Proteus vulgaris 86 76 40 81 81 42 74 33 
Pseudomonas aeruginosa 85 77 38 82 86 46 71 35 
Serratia marcescens 87 79 39 83 94 47 73 37 
AM = Ampicillin, AUC = Amoxicillin/Clavulanic Acid, PPL= Piperacillin /Tazobactam, CZ = Cefazolin, CI = 
Ceftriaxone, CEF = Cefepime, and AZ = Aztreonam, EPM = Ertapenem. 
 
Bacterial isolates Percentage of resistance 
IPM MPM AK GM CIP LEV T TRI 
Acinetobacter baumannii 37 33 40 70 33 39 80 88 
Enterobacter cloacae 33 34 39 72 30 37 88 85 
Escherichia coli 39 32 41 73 34 33 82 80 
Klebsiella oxytoca 33 35 40 77 36 31 85 80 
Klebsiella pneumonia 35 34 39 74 33 38 80 84 
Micrococcus luteus 38 33 40 72 38 36 83 82 
Morganella morganii 37 37 38 75 31 36 82 88 
Proteus mirabilis 39 30 33 70 38 38 80 87 
Proteus vulgaris 33 37 36 75 35 32 84 85 
Pseudomonas aeruginosa 37 37 38 75 31 36 82 88 
Serratia marcescens 39 30 33 70 38 38 80 87 
IPM= Imipenem, MPM= Meropenem, AK= Amikacin, GM= Gentamicin, CIP= Ciprofloxacin, LEV= 
Levofloxacin, T= Tetracycline, and TRI= Ttimethprim / Sulfamethoxazole. 
   The antimicrobial susceptibility test against gram positive bacteria shows all isolates were resistance to 
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Cefoxitin Screen, Benzylpenicillin, Ampicillin, Oxacillin, Gentamicin, Erythromycin, Quinupristin / Dalfopristin, 
Vancomycin, Tetracycline, Rifampicin, Trimethoprim / Sulfamethoxazole,  and sensitive to  Gentamicin High 
Level, Strepmycin, High Level Ciprofloxacin, Levofloxacin, Moxifloxacin, Inducible Clindamycin Resistance,  
Clindamycin, and Tigecycline (Table 3). 
 
  Table 3: Susceptibility tests of antimicrobials on gram positive bacteria isolated from UTI patients. 
Bacterial isolates Percentage of resistance 
CEF BEP AM OX GM HL S HL GM CIP LEV MOF 
Enterococcus cloacae 67 63 68 70 30 33 66 30 31 32 
Enterococcus faecalis 77 73 78 80 38 37 76 33 35 33 
Staphylococcus aureus 74 77 76 84 39 33 74 30 32 32 
Staph. Haemolyticus 76 75 79 83 37 35 77 31 33 34 
CEF = Cefoxitin Screen, BEP = Benzylpenicillin, AM = Ampicillin, OX= Oxacillin, GMHL= Gentamicin High 
Level, SHL= Strepmycin High Level, GM = Gentamicin, CIP = Ciprofloxacin, LEV = Levofloxacin, & MOF 
Moxifloxacin. 
 
Bacterial isolates Percentage of resistance 
I CLM R E CLM QUP V T TIG F RIP TRI 
Enterococcus cloacae 33 80 40 78 57 75 41 87 54 67 
Enterococcus faecalis 37 90 44 88 55 81 43 90 55 77 
Staphylococcus aureus 38 87 43 85 56 80 45 91 70 74 
Staph. Haemolyticus 33 88 45 87 60 79 47 92 71 70 
ICLMR = Inducible Clindamycin Resistance, E = Erythromycin, CLM = Clindamycin, QUP = Quinupristin / 
Dalfopristin, V = Vancomycin, T = Tetracycline, TIG = Tigecycline, F = Nitrofurantoin, RIP = Rifampicin, & 
TRI = Trimethoprim / Sulfamethoxazole.  
  The result of Minimum Inhibitory Concentration of antimicrobials against gram negative bacteria Isolates 
shows that the MIC of Ampicillin, Amoxicillin/Clavulanic Acid, Cefazolin, Ceftriaxone, Aztreonam, 
Gentamicin and Tetracycline were  (≤ 16 - ≤ 32  µg/mL), the MIC of Ttimethprim/Sulfamethoxazole was (≤ 160 
- ≤ 320  µg/mL), the MIC of Piperacillin/Tazobactam was (≤ 4 - ≤ 8  µg/mL), the MIC of Cefepime was (≤ 1 - ≤ 
4 µg/mL), the MIC of  Ertapenem and Meropenem were (≤ 0.125 - ≤ 1 µg/mL), the MIC of Imipenem was (≤ 1 - 
≤ 2 µg/mL), the MIC of Amikacin was (≤ 2 - ≤ 8  µg/mL), the MIC of  Ciprofloxacin was (≤ 0.25 - ≤ 2  µg/mL),  
the MIC of  Levofloxacin was (≤ 0.5 - ≤ 1  µg/mL) Table (4).  
 
 Table 4: Minimum Inhibitory Concentration of antimicrobials against gram negative bacteria Isolates 
from UTI patients. 
Bacterial isolates MIC (µg/l) 
AM AUC PPL CZ CI CEF AZ EPM 
Acinetobacter baumannii ≤16 - ≤ 32 
 
≤16 - ≤ 32 
 
≤4 - ≤ 8 
 
≤32- ≤ 64 
 
≤32- ≤ 64 
 
≤1 - ≤ 4 
 
≤16 - ≤ 32 
 
≤0.125- ≤ 1 
 
Enterobacter cloacae ≤16 - ≤ 32 
 
≤16 - ≤ 32 
 
≤4 - ≤ 8 ≤32- ≤ 64 
 
≤32- ≤ 64 
 
≤1 - ≤ 4 
 
≤16 - ≤ 32 
 
≤0.125- ≤ 1 
 
Escherichia coli ≤16 - ≤ 32 
 
≤16 - ≤ 32 
 
≤4 - ≤ 8 ≤32- ≤ 64 
 
≤32- ≤ 64 
 
≤1 - ≤ 4 
 
≤16 - ≤ 32 
 
≤0.125- ≤ 1 
 
Klebsiella oxytoca ≤16 - ≤ 32 
 
≤16 - ≤ 32 
 
≤4 - ≤ 8 ≤32- ≤ 64 
 
≤32- ≤ 64 
 
≤1 - ≤ 4 
 
≤16 - ≤ 32 
 
≤0.125- ≤ 1 
 
Klebsiella pneumonia ≤16 - ≤ 32 
 
≤16 - ≤ 32 
 
≤4 - ≤ 8 ≤32- ≤ 64 
 
≤32- ≤ 64 
 
≤1 - ≤ 4 
 
≤16 - ≤ 32 
 
≤0.125- ≤ 1 
 
Micrococcus luteus ≤16 - ≤ 32 
 
≤16 - ≤ 32 
 
≤4 - ≤ 8 ≤32- ≤ 64 
 
≤32- ≤ 64 
 
≤1 - ≤ 4 
 
≤16 - ≤ 32 
 
≤0.125- ≤ 1 
 
Morganella morganii ≤16 - ≤ 32 
 
≤16 - ≤ 32 
 
≤4 - ≤ 8 ≤32- ≤ 64 
 
≤32- ≤ 64 
 
≤1 - ≤ 4 
 
≤16 - ≤ 32 
 
≤0.125- ≤ 1 
 
Proteus mirabilis ≤16 - ≤ 32 
 
≤16 - ≤ 32 
 
≤4 - ≤ 8 ≤32- ≤ 64 
 
≤32- ≤ 64 
 
≤1 - ≤ 4 
 
≤16 - ≤ 32 
 
≤0.125- ≤ 1 
 
Proteus vulgaris ≤16 - ≤ 32 
 
≤16 - ≤ 32 
 
≤4 - ≤ 8 ≤32- ≤ 64 
 
≤32- ≤ 64 
 
≤1 - ≤ 4 
 
≤16 - ≤ 32 
 
≤0.125- ≤ 1 
 
Pseudomonas aeruginosa ≤16 - ≤ 32 
 
≤16 - ≤ 32 
 
≤4 - ≤ 8 ≤32- ≤ 64 
 
≤32- ≤ 64 
 
≤1 - ≤ 4 
 
≤16 - ≤ 32 
 
≤0.125- ≤ 1 
 
Serratia marcescens ≤16 - ≤ 32 
 
≤16 - ≤ 32 
 
≤4 - ≤ 8 ≤32- ≤ 64 
 
≤32- ≤ 64 
 
≤1 - ≤ 4 
 
≤16 - ≤ 32 
 
≤0.125- ≤ 1 
 
AM= Ampicillin, AUC= Amoxicillin/Clavulanic Acid, PPL= Piperacillin/Tazobactam, CZ= Cefazolin, CI= 
Ceftriaxone, CEF= Cefepime, AZ= Aztreonam, & EPM= Ertapenem. 
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Bacterial isolates MIC (µg/l) 
IPM MPM AK GM CIP LEV T TRI 
Acinetobacter baumannii ≤1- ≤ 2 
 
≤0.125 - ≤ 1 
 
≤2 - ≤ 8 
 
≤16 - ≤ 32 
 
≤0.25 - ≤ 2 
 
≤0.5 - ≤ 1 
 
≤16 - ≤ 32 
 
≤160 - ≤ 320 
Enterobacter cloacae ≤1- ≤ 2 ≤0.125 - ≤ 1 
 
≤2 - ≤ 8 
 
≤16 - ≤ 32 
 
≤0.25 - ≤ 2 
 
≤0.5 - ≤ 1 
 
≤16 - ≤ 32 
 
≤160 - ≤ 320 
Escherichia coli ≤1- ≤ 2 ≤0.125 - ≤ 1 
 
≤2 - ≤ 8 
 
≤16 - ≤ 32 
 
≤0.25 - ≤ 2 
 
≤0.5 - ≤ 1 
 
≤16 - ≤ 32 
 
≤160 - ≤ 320 
Klebsiella oxytoca ≤1- ≤ 2 ≤0.125 - ≤ 1 
 
≤2 - ≤ 8 
 
≤16 - ≤ 32 
 
≤0.25 - ≤ 2 
 
≤0.5 - ≤ 1 
 
≤16 - ≤ 32 
 
≤160 - ≤ 320 
Klebsiella pneumonia ≤1- ≤ 2 ≤0.125 - ≤ 1 
 
≤2 - ≤ 8 
 
≤16 - ≤ 32 
 
≤0.25 - ≤ 2 
 
≤0.5 - ≤ 1 
 
≤16 - ≤ 32 
 
≤160 - ≤ 320 
Micrococcus luteus ≤1- ≤ 2 ≤0.125 - ≤ 1 
 
≤2 - ≤ 8 
 
≤16 - ≤ 32 
 
≤0.25 - ≤ 2 
 
≤0.5 - ≤ 1 
 
≤16 - ≤ 32 
 
≤160 - ≤ 320 
Morganella morganii ≤1- ≤ 2 ≤0.125 - ≤ 1 
 
≤2 - ≤ 8 
 
≤16 - ≤ 32 
 
≤0.25 - ≤ 2 
 
≤0.5 - ≤ 1 
 
≤16 - ≤ 32 
 
≤160 - ≤ 320 
Proteus mirabilis ≤1- ≤ 2 ≤0.125 - ≤ 1 
 
≤2 - ≤ 8 
 
≤16 - ≤ 32 
 
≤0.25 - ≤ 2 
 
≤0.5 - ≤ 1 
 
≤16 - ≤ 32 
 
≤160 - ≤ 320 
Proteus vulgaris ≤1- ≤ 2 ≤0.125 - ≤ 1 
 
≤2 - ≤ 8 
 
≤16 - ≤ 32 
 
≤0.25 - ≤ 2 
 
≤0.5 - ≤ 1 
 
≤16 - ≤ 32 
 
≤160 - ≤ 320 
Pseudomonas aeruginosa ≤1- ≤ 2 ≤0.125 - ≤ 1 
 
≤2 - ≤ 8 
 
≤16 - ≤ 32 
 
≤0.25 - ≤ 2 
 
≤0.5 - ≤ 1 
 
≤16 - ≤ 32 
 
≤160 - ≤ 320 
Serratia marcescens ≤1- ≤ 2 ≤0.125 - ≤ 1 
 
≤2 - ≤ 8 
 
≤16 - ≤ 32 
 
≤0.25 - ≤ 2 
 
≤0.5 - ≤ 1 
 
≤16 - ≤ 32 
 
≤160 - ≤ 320 
IPM= Imipenem, MPM= Meropenem, AK= Amikacin, GM= Gentamicin, CIP= Ciprofloxacin, LEV= 
Levofloxacin, T= Tetracycline, TRI= Ttimethprim/Sulfamethoxazole. 
The result of Minimum Inhibitory Concentration of antimicrobials against gram positive bacteria Isolates shows 
that the MIC of Cefoxitin Screen was (≤ 8 - ≤ 16  µg/mL), the MIC of Benzylpenicillin, Ampicillin, Oxacillin,  
Gentamicin, Quinupristin/Dalfopristin, Vancomycin and Rifampicin were (≤ 16 - ≤ 32  µg/mL), the MIC of 
Gentamicin High Level,  Strepmycin High Level and Levofloxacin were  (≤ 1- ≤ 4  µg/mL), the MIC of 
Ciprofloxacin was (≤ 0.5 - ≤ 1  µg/mL), the MIC of Moxifloxacin was (≤ 0.125 - ≤ 1  µg/mL),  the MIC of  
Inducible Clindamycin Resistance was  (≤ 0.5 - ≤ 2  µg/mL),  the MIC of Erythromycin and Tetracycline  were 
(≤ 8 - ≤ 16  µg/mL), the MIC of  Clindamycin and Tigecycline were  (≤ 0.25 - ≤ 1  µg/mL), the MIC of  
Nitrofurantoin was  (≤ 64- ≤ 256  µg/mL), the MIC of  Trimethoprim/Sulfamethoxazole was (≤ 160 - ≤ 320  
µg/mL) (Table 5). 
 
 Table 5: Minimum Inhibitory Concentration of antimicrobials against gram positive bacteria Isolates 
from UTI patients. 
I. 
No. 
MIC (µg/l) 
CEF BEP AM OX GM HL S HL GM CIP LEV MOF 
1 ≤8 - ≤ 16 
 
≤1 - ≤ 8 
 
≤16 - ≤ 32 
 
≤4 - ≤ 16 
 
≤1 - ≤ 4 
 
≤1 - ≤ 4 
 
≤16 - ≤ 32 
 
≤0.5- ≤1 ≤1- ≤4 
 
≤.125- ≤1 
 
2 ≤8 - ≤ 16 
 
≤1 - ≤ 8 
 
≤16 - ≤ 32 
 
≤4 - ≤ 16 
 
≤1 - ≤ 4 
 
≤1 - ≤ 4 
 
≤16 - ≤ 32 
 
≤0.5- ≤1 ≤1- ≤4 
 
≤.125- ≤1 
 
3 ≤4 - ≤ 8 
 
≤1 - ≤ 8 
 
≤8 - ≤ 16 
 
≤8 - ≤ 16 
 
≤1 - ≤ 4 
 
≤1 - ≤ 4 
 
≤16 - ≤ 32 
 
≤0.5- ≤1 ≤1- ≤4 
 
≤.125- ≤1 
 
4 ≤8 - ≤ 16 
 
≤1- ≤ 4 
 
≤8 - ≤ 16 
 
≤8 - ≤ 16 
 
≤1 - ≤ 4 
 
≤1 - ≤ 4 
 
≤16 - ≤ 32 
 
≤0.5- ≤1 ≤1- ≤4 
 
≤.125- ≤1 
 
1= Enterococcus faecalis, 2= Staphylococcus aureus, 3= Staphylococcus haemolyticus, 4= Staphylococcus 
hominis. I. No. = Isolate Number. 
CEF= Cefoxitin Screen, BEP= Benzylpenicillin, AM= Ampicillin, OX= Oxacillin, GMHl= Gentamicin High 
Level, SHL= Strepmycin High Level, GM= Gentamicin, CIP= Ciprofloxacin, LEV=Levofloxacin, MOF= 
Moxifloxacin. 
 
I. No. MIC (µg/l) 
I CLM 
R 
E CLM QUP V T TIG F RIP TRI 
1 ≤0.5 - ≤ 2 
 
≤8 - ≤ 16 
 
≤0.25 - ≤ 1 
 
≤16 - ≤ 32 
 
≤0.5 - ≤ 1 
 
≤8 - ≤ 16 
 
≤0.25 - ≤ 1 
 
≤64 - ≤ 256 
 
≤0.5- ≤ 1 
 
≤160 - ≤ 320 
 
2 ≤0.5 - ≤ 2 
 
≤8 - ≤ 16 
 
≤0.25 - ≤ 1 
 
≤16 - ≤ 32 
 
≤0.5 - ≤ 1 
 
≤8 - ≤ 16 
 
≤0.25 - ≤ 1 
 
≤64 - ≤ 256 
 
≤0.5- ≤ 1 
 
≤160 - ≤ 320 
 
3 ≤0.5 - ≤ 2 
 
≤8 - ≤ 16 
 
≤0.25 - ≤ 1 
 
≤16 - ≤ 32 
 
≤16 - ≤ 32 
 
≤8 - ≤ 16 
 
≤0.25 - ≤ 1 
 
≤64 - ≤ 256 
 
≤16- ≤ 32 
 
≤160 - ≤ 320 
 
4 ≤0.5 - ≤ 2 
 
≤8 - ≤ 16 
 
≤0.25 - ≤ 1 
 
≤16 - ≤ 32 
 
≤16 - ≤ 32 
 
≤8 - ≤ 16 
 
≤0.25 - ≤ 1 
 
≤64 - ≤ 256 
 
≤16- ≤ 32 
 
≤160 - ≤ 320 
 
1= Enterococcus faecalis, 2= Staphylococcus aureus, 3= Staphylococcus haemolyticus, 4= Staphylococcus 
hominis. I. No. = Isolate Number. ICLMR=Inducible Clindamycin Resistance, E= Erythromycin, CLM= 
Clindamycin, QUP = Quinupristin / Dalfopristin, V = Vancomycin, T = Tetracycline, TIG = Tigecycline, F = 
Nitrofurantoin, RIP = Rifampicin, & TRI = Trimethoprim / Sulfamethoxazole. 
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The data in (Table 6) shows that Drink of the Prophet Mohammad (Kefiran) has effective antibacterial activities 
on the UTIs isolates as indicated by the diameter of their zone of inhibition. The effect of Drink of the Prophet 
Mohammad (Kefiran) on all isolates was at 24 hours of incubation, the diameter of inhibition zone was 7mm for 
Acinetobacter baumannii, Enterobacter cloacae, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumonia, 
Morganella morganii, Proteus vulgaris, Serratia marcescens, and Enterococcus faecalis. 8mm for Micrococcus 
luteus, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus aureus and Staphylococcus haemolyticus. 
The effect at 48 hours of incubation was 8mm for Acinetobacter baumannii, Enterobacter cloacae, Escherichia 
coli, Klebsiella oxytoca, Klebsiella pneumonia, Morganella morganii, Proteus vulgaris, Serratia marcescens, 
Enterococcus cloacae and Enterococcus faecalis. 9mm for Micrococcus luteus, Proteus mirabilis, Pseudomonas 
aeruginosa, Staphylococcus aureus and Staphylococcus haemolyticus. The diameter of inhibition zone at 72 
hours of incubation was 10mm for Acinetobacter baumannii, Klebsiella oxytoca, Micrococcus luteus, 
Morganella morganii, Proteus mirabilis, Proteus vulgaris, Pseudomonas aeruginosa and Enterococcus cloacae. 
11mm for Enterobacter cloacae, Escherichia coli, Klebsiella pneumonia, Enterococcus faecalis, Staphylococcus 
aureus and Staphylococcus haemolyticus. The maximum activity of the Prophet Mohammad Drink's was 
recorded at 96 hours of incubation of grains of the Prophet Mohammad (kefir grains) against all isolates; the 
inhibition zone was between (10-12 mm). 
 
Table 6: Antimicrobial activities of drink of Prophet Mohammed (kefiran) on bacteria isolated from UTI 
patients. 
 
Bacterial isolates 
 
Incubation periods of drink of prophet mohammed 
0 hrs. 
I.Z(mm) 
24 hrs. 
I.Z.(mm) 
48 hrs. 
I.Z.(mm) 
72 hrs. 
I.Z.(mm) 
96 hrs. 
I.Z.(mm) 
Acinetobacter baumannii 0.0 7.0 8.0 10.0 10.0 
Enterobacter cloacae 0.0 7.0 8.0 11.0 12.0 
Escherichia coli 0.0 7.0 8.0 11.0 12.0 
Klebsiella oxytoca 0.0 7.0 8.0 10.0 11.0 
Klebsiella pneumonia 0.0 7.0 8.0 11.0 11.0 
Micrococcus luteus 0.0 8.0 9.0 10.0 11.0 
Morganella morganii 0.0 7.0 8.0 10.0 10.0 
Proteus mirabilis 0.0 8.0 9.0 10.0 12.0 
Proteus vulgaris 0.0 7.0 8.0 10.0 10.0 
Pseudomonas aeruginosa 0.0 8.0 9.0 10.0 12.0 
Serratia marcescens 0.0 7.0 8.0 11.0 12.0 
Enterococcus cloacae 0.0 8.0 9.0 11.0 12.0 
Enterococcus faecalis 0.0 8.0 9.0 11.0 12.0 
Staphylococcus aureus 0.0 8.0 9.0 11.0 12.0 
Staphylococcus haemolyticus 0.0 8.0 9.0 11.0 12.0 
I.Z. = Inhibition Zone.   
 
4. Dissection 
Several species of bacteria were isolated from patients with urethral tract infections which included 
Acinetobacter baumannii, Enterobacter cloacae, Enterococcus cloacae, Enterococcus faecalis, Escherichia coli, 
Klebsiella oxytoca, Klebsiella pneumonia, Micrococcus luteus, Morganella morganii, Proteus mirabilis, Proteus 
vulgaris, Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus aureus and Staphylococcus 
haemolyticus. Similar organisms have been reported [24, 29]. Overall, the evaluation results of the newly 
redesigned colorimetric VITEK-2 ID was so impressed by the performance because more than 98% of the 
isolates were correctly identified to the species level without any further additional tests. Also, the present results 
indicated that the current VITEK-2 has overcome its inherent weakness in IDs of streptococci and glucose-
nonfermentative GNR. Until present, API test strips has been long considered as the gold standard Q in ID test 
[28, 30]. But the accuracy of the VITEK-2 was finally estimated to be 98.3%, compared with 97.5% by the 
respective API test strips. Our results were highly consistent with a series of evaluation results recently published 
for GPC [31], GNR [32]. 
The antimicrobial activities of commercially prepared antibiotics on the bacterial isolates showed, that 
all isolates were sensitive to quinolones (Ciprofloxacin, Levofloxacin and Ofloxacin) this agree with many 
references which showed that most bacteria isolated from UTIs patient were sensitive to quinolones compounds 
[33, 34, 35]. The resistance to other types of antimicrobials differs with different isolates; these are in agreement 
with [36]. The interpretation of results due to littleness using of Quinolones in Baghdad hospitals compared with 
other antimicrobials such as Ampicillin, Chloramphenicol, Erythromycin, Gentamicin and Oxacillin. The 
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maximum antimicrobial effect of Drink of the prophet Mohammed (kefiran) noted at 72 and 96 hours of 
incubation table (6), in these periods the largest inhibition zones were recorded, these finding were in agreement  
with several references [36, 37,10]. The antimicrobial activity of (DPM) under different incubation periods 
studied against a number of pathogenic microorganisms which causes urethral tract infections, DPM had its 
strongest antimicrobial effects, and this implies the existence of an antimicrobial component other than acetic 
acid and large proteins. There are numerous reports indicating that a decrease in the pH of Kefir beverage is 
caused by the accumulation of organic acids, produced as major end-products of carbohydrate metabolism by 
lactic acid bacteria (LAB). Accumulation of lactic acid and a subsequent decrease in pH results in a broad-
spectrum inhibitory activity against Gram-negative bacteria [38]. The undissociated forms of lactic and acetic 
acid penetrate the microbial cell membrane. This results in acidification of the cytoplasm and the formation of 
inhibition, especially against enzymes, by salt excesses [3]. At a higher intracellular pH these acids dissociate to 
produce hydrogen ions, which interfere with important metabolic functions such as oxidative phosphorylation 
and substrate translocation [4]. The antimicrobial effect of lactic or acetic acid depends on the pKₐ value of the 
acid, as well as the pH of the external environment [5, 6]. These acids are known to inhibit E. coli [7] and B. 
cereus [8]. At a pH 5.0 acetic acid inhibits the growth of Salmonella typhimurium [9]. A synergism between 
lactic and acetic acid has been reported for the inhibition of E.coli and Salmonella spp. [10, 11]. Lactic acid (pKₐ 
3.86) is a stronger acid than acetic acid (pKₐ 4.75) [12] and in well-buffered foods with a pH of 4-6, acetate has a 
stronger antimicrobial effect as a greater portion of the acid is undissociated [13]. The second factor found in 
DPM which have antimicrobial activity is hydrogen peroxide (H2O2). The production of hydrogen peroxide 
(H2O2) by lactic acid bacteria depends on the strain and the availability of oxygen [1]. In the presence of oxygen, 
H2O2 is produced by lactic acid bacteria through electron transport via flavin enzymes. In the presence of H2O2, 
superoxide anions from destructive hydroxy radicals (OH), leading to increased membrane permeability [3] and 
to the peroxidation of membrane lipids [4]. Bactericidal oxygen metabolites cause the destruction of nucleic 
acids and cell proteins, and have a strong oxidizing effect on the bacterial cell [5, 6, 7]. Hydrogen peroxide 
accumulates in the growth media and inhibits Pseudomonas spp. [8] and S. aureus [9]. Inhibitory compounds can 
also be formed from H2O2, such as in raw milk where it reacts with endogenous thiocyanate, catalyzed by 
lactoperoxidase [10, 11].  The third factor found in DPM is Carbon dioxide; Carbon dioxide contributes to the 
antimicrobial activity of lactic acid bacteria by replacing the existing molecular oxygen, creating an anaerobic 
environment [1]. The forth factor found in DPM is Acetaldehyde, at concentration of 10 to 100 ppm has 
antimicrobial activity against Staphylococcus aureus, E. coli and Salmonella typhimurium [1, 3, 4]. The fifth 
factor found in DPM is Diacetyl (2, 3-butanedione) is an end-product of pyruvate metabolism [5] of citrate-
fermenting lactic acid bacteria [6, 7] that elicits antimicrobial activity against various spoilage microorganisms 
and food-borne pathogens [8, 9]. Diacetyl is effective against yeasts, moulds and Gram-negative bacteria. Archer 
et al., (1996) reported the inhibition of S. typhimurium by sublethal concentrations of diacetyl. The compound 
reacts with arginine-binding proteins of Gram-negative bacteria and interferes with arginine utilization [9, 10, 
11]. High concentrations of diacetyl are required for an antimicrobial effect. Dose-dependent inhibition 
experiments established that 0.2 mg.ml¯¹ is required for the antimicrobial activity against Gram-negative 
bacteria and yeasts, while 0.3 mg.ml¯¹ is required for he inhibition of non-lactic Gram-positive bacteria [2, 9].  
The sixth factor found in DPM is Bacteriocins are bacterial proteins or peptide with bactericidal or bacteriostatic 
activity against genetically closely related species [40]. Bacteriocins generally vary with regards to their mode of 
action, molecular weight, genetic origin, biochemical properties and spectrum of activity. The can be produced 
spontaneously or induced and the genetic determinants of most bacteriocins are located on plasmids, with only a 
few exceptions being chromosomal encoded [38]. The release of bacteriocins from producer cells requires the 
expression and activity of bacteriocin-release proteins, and the presence of detergent resistant phospholipase A in 
the bacterial outer membrane [38]. The bacteriocins that are released are species specific. The majority of 
bacteriocins produced by lactic acid bacteria have been characterised according to their activity as a 
proteinaceous inhibitor, on the estimation of their molecular mass, and on the determination of their spectrum of 
inhibition [41]. Bacteriocins inhibit a broad spectrum of Gram-positive and Gram-negative bacteria [4]. 
Antimicrobial activity increased with fermentation time until 96 hours, these finding in agreement with [10]. As 
seen in almost all cases tested. This also implies that the active antimicrobial components are very likely 
metabolites produced by the bacteria and/or yeasts responsible for the fermentation of Drink of the Prophet 
Mohammad. 
 
5. Conclusion 
The antibacterial activity of Drink of the Prophet Mohammad (Kefir) increase with increase incubation periods 
(96 hours). 
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